Stockscreener 앱 받기
342.41
0.60%
-2.06
시장 영업 전:
343.08
0.67
+0.20%
전일 마감가:
$344.47
열려 있는:
$341.77
하루 거래량:
119.78K
Relative Volume:
0.69
시가총액:
$9.59B
수익:
$2.58B
순이익/손실:
$-778.69M
주가수익비율:
-12.53
EPS:
-27.33
순현금흐름:
$223.75M
1주 성능:
+0.19%
1개월 성능:
+1.35%
6개월 성능:
+7.46%
1년 성능:
+12.59%
1일 변동 폭
$341.38
$345.76
1주일 범위
$334.57
$355.05
52주 변동 폭
$262.12
$387.99
Bio Rad Laboratories Inc Stock (BIO) Company Profile
명칭
Bio Rad Laboratories Inc
전화
(510) 724-7000
주소
1000 ALFRED NOBEL DRIVE, HERCULES
BIO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BIO
Bio Rad Laboratories Inc
|
342.41 | 9.59B | 2.58B | -778.69M | 223.75M | -27.33 |
|
ABT
Abbott Laboratories
|
113.48 | 196.83B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
383.42 | 146.17B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
98.66 | 145.41B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
88.08 | 112.94B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
69.78 | 41.16B | 6.60B | 4.16B | 490.10M | 6.93 |
Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-10-01 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-08-28 | 개시 | Wells Fargo | Equal Weight |
| 2024-06-03 | 재개 | Jefferies | Hold |
| 2024-04-03 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2023-12-07 | 개시 | UBS | Buy |
| 2023-06-16 | 개시 | Wells Fargo | Overweight |
| 2022-12-07 | 개시 | RBC Capital Mkts | Outperform |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-01-28 | 재확인 | Citigroup | Buy |
| 2020-01-08 | 개시 | Wells Fargo | Overweight |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2018-10-17 | 개시 | Goldman | Buy |
| 2018-09-20 | 개시 | Morgan Stanley | Equal-Weight |
| 2018-02-16 | 다운그레이드 | CL King | Buy → Neutral |
| 2017-07-13 | 개시 | Wells Fargo | Outperform |
| 2017-06-28 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2017-01-18 | 개시 | Deutsche Bank | Hold |
| 2016-10-13 | 개시 | CL King | Buy |
| 2015-05-06 | 재확인 | Jefferies | Buy |
| 2009-12-18 | 개시 | Maxim Group | Buy |
| 2009-11-06 | 개시 | Jefferies & Co | Buy |
| 2009-07-17 | 개시 | Soleil | Buy |
| 2007-09-26 | 개시 | Banc of America Sec | Buy |
| 2007-02-23 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
모두보기
Bio Rad Laboratories Inc 주식(BIO)의 최신 뉴스
Biomarker Testing Market Projected to Reach Huge Growth by 2031 - openPR
Laboratory Equipment Market: Projected Significant CAGR with - openPR
Saudi Arabia IVD Market Outlook & Company Analysis 2025-2033, Featuring Roche Diagnostics, Danaher, Abbott Laboratories, Thermo Fischer Scientific, Bio-Rad Laboratories, Sysmex, Becton and Biomerieux - Yahoo Finance
Bio-Rad Laboratories, Inc. (NYSE:BIO) Short Interest Up 18.8% in December - MarketBeat
Malaria Diagnostics Market Investment Opportunities: A Guide to 2031 | Nikon Corporation, Bio-Rad Laboratories - EIN News
RNA Transcriptome Profiling Tests Market Expands at 14.5% CAGR, Surpassing US$ 37 Billion by 2034 | Fact.MR Report - GlobeNewswire Inc.
Why Bio-Rad Stock is an Apt Pick for Your Portfolio Right Now - MSN
Wedge Capital Management L L P NC Takes $28.74 Million Position in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
Geneoscopy, Inc. announced that it expects to receive $120.850521 million in funding -October 30, 2024 - Marketscreener.com
Is Adaptive Biotechnologies (ADPT) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Bio-Rad Launches Nuvia wPrime 2A Media for Biomolecule Purification - Technology Networks
Biotech bi-weekly: 2025 launches with a deluge of industry partnerships - BioTechniques
Contravisory Investment Management Inc. Takes Position in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
Research Analysts Set Expectations for BIO FY2024 Earnings - MarketBeat
Bio-Rad launches Nuvia wPrime 2A Media for biomolecule purification - SelectScience
Next Generation Sequencing Market Size, Share, Industry - openPR
Genomics Market Is Expected To Reach USD 115.4 Billion By 2031Agilent Technologies, Bio-Rad Laboratories Inc - openPR
Genetic Testing Market: Projected Positive Growth Trends - openPR
Laboratory Equipment and Disposables Market Overall Study - openPR
Bio-Rad launches Nuvia wPrime 2A media for biomolecule purification - Cambridge Network
Sample Preparation Market Generated Opportunities, Future Scope by 2031 | F. Hoffmann-La Roche AG, Bio-Rad - EIN News
The Analyst Verdict: Bio-Rad Laboratories In The Eyes Of 4 Experts - Benzinga
Bio-Rad Laboratories' (BIO) "Outperform" Rating Reaffirmed at Royal Bank of Canada - MarketBeat
Animal Health Diagnostics Market to grow by USD 2.1 Billion (2025-2029), driven by rising pet humanization, report highlights AI-driven market trendsTechnavio - The Malaysian Reserve
(BIO) Technical Data - Stock Traders Daily
Microfluidic Devices Market Global Outlook 2025-2035, with Company Profiles of the Top 10+ Major Market Players - GlobeNewswire
Expanded range of prepacked chromatography columns for biotherapeutic purification - Labmate Online
JPMorgan Chase & Co. Sells 4,840 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
Biosensors Market Overall Study Report 2024-2031 | Bio-Rad Laboratories Inc., Medtronic - EIN News
Diversified Trust Co Takes $958,000 Position in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
Flow Cytometry in Oncology and Immunology Market Top Players - openPR
HIV Diagnostics Test Market Is Booming Worldwide 2025-2032 | - openPR
Global cDNA Reverse Transcription Kit Market Size 2025-2032: Man - WICZ
Growth Trends in the Pediatric Cancer Biomarkers Market, - GlobeNewswire
Growth Trends in the Pediatric Cancer Biomarkers Market, 2024-2034Roche, Thermo Fisher Scientific, Illumina, QIAGEN, and Bio-Rad Laboratories Dominate the Competition - Yahoo Finance
Laboratory Supplies Market Overall Study Report 2025-2032 | - openPR
Bio-Rad Laboratories (NYSE:BIO.B) Shares Gap UpShould You Buy? - MarketBeat
Geneoscopy Closes $105M in Series C Funding Round to Power Next-Generation of Gastrointestinal Diagnostic Tests - Business Wire
Bio-Rad extends range of Foresight Pro prepacked chromatography columns for biotherapeutic production - SelectScience
DNA Methylation Market Set to Witness Significant Growth - openPR
Bio-Rad Extends Range of Foresight Pro Prepacked Chromatography Columns for Biotherapeutic Production - Technology Networks
Geneoscopy Raises $105M to Launch Revolutionary Non-Invasive Cancer Screening Test ColoSense - StockTitan
Biomarker Research Services Market Generated Opportunities, - openPR
Bio-Rad Expands Chromatography Columns for Biotherapeutic Production - Contract Pharma
Cell Culture Market Top PlayersCargill Inc., Bio-Rad Laboratories, Inc.; Thermo Fisher Scientific, Inc.; Becton. - openPR
Getting In Cheap On Bio-Rad Laboratories, Inc. (NYSE:BIO) Is Unlikely - Simply Wall St
CEACAM8 Antigen Gene Market Top PlayersThermo Fisher - openPR
Bio-Rad (BIO) to Report Q2 Earnings: What's in the Cards? - MSN
Hemoglobin A1c (HbA1c) Testing Market Projected to Reach $1.83 Billion by 2024, Growth Fueled by Rising Prevalence of Diabetes - GlobeNewswire Inc.
Bio-Rad Laboratories, Inc. (NYSE:BIO) Receives $394.20 Average PT from Brokerages - MarketBeat
Transplant Diagnostics Market Top Companies StudyBioMerieux - openPR
Bio Rad Laboratories Inc (BIO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.25%
0.57%
자본화:
|
볼륨(24시간):